NEW YORK (GenomeWeb) – Bruker said today that it has acquired informatics firm Scils and reagents manufacturer InVivo Biotech Services.

Both acquisitions add to Bruker's life sciences portfolio with Scils bringing expertise in areas including analysis and visualization of imaging mass spectrometry data and InVivo providing expertise in manufacturing monoclonal antibodies and recombinant proteins as well as custom immunoassays and research kits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.